|
|
Volumn 2, Issue 4 Suppl 1, 2003, Pages
|
|
Inhibiting tyrosine kinases: successes and limitations.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
IMATINIB;
MONOCLONAL ANTIBODY;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
TRASTUZUMAB;
ANIMAL;
BREAST TUMOR;
CLINICAL TRIAL;
DRUG ANTAGONISM;
ENZYMOLOGY;
HUMAN;
NEOPLASM;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
HUMANS;
NEOPLASMS;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
MLCS;
MLOWN;
|
|
EID: 1542751704
PISSN: 15384047
EISSN: None
Source Type: Journal
DOI: 10.4161/cbt.206 Document Type: Review |
|
Times cited : (24)
|
|
References (57)
|
